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Abstract
Background: Neurotoxic envenomation following bites by kraits (Bungarus species) is a leading cause of snakebite
mortality in South Asia. Over a long time, this had been attributed only to one species, the common krait (Bungarus
caeruleus). However, recent research has provided increasing evidence of the involvement of several krait species.
Here, we report a fatal case of neurotoxic envenomation following the bite of a greater black krait (Bungarus niger)
in Nepal.
Case presentation: A 33-year-old man was bitten in the outdoor corridor of his home in the eastern hills of Ilam
district while handling a snake he thought to be non-venomous. He subsequently developed severe abdominal
pain, frequent vomiting, and signs of neurotoxic envenomation leading to respiratory paralysis. The patient did not
respond to Indian polyvalent antivenom given 4 h after the bite and died under treatment 8 h after the bite. This is
the second time that a B. niger was observed in Nepal, the first documented case of envenomation by this species
in the country and the sixth reported case worldwide.
Conclusions: Previous distribution records – from eastern India and western Nepal, from western hills in Nepal, and
from lowland localities in India and Bangladesh – indicate risk of envenomation by B. niger throughout the low and
intermediate elevations of Nepal up to at least 1,500 m above sea level. As very few people in Nepal bring killed
snakes to healthcare centers and because there is a general belief among local people that there are no kraits in
the hills, bites by B. niger are likely to be misdiagnosed and underreported.
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Background
For a very long time, krait bite envenomation in South
Asia was thought to be due to a single species, the
widely distributed common krait (Bungarus caeruleus),
whose venom has consequently been used in the produc-
tion of polyvalent antivenoms in India [1]. However,
several other species of krait occur in South Asia, and
some of these were recently shown to contribute to
regional snakebite morbidity and mortality [2–7].
The greater black krait (Bungarus niger Wall, 1908)
is widely distributed in South and Southeast Asia
where it has been recorded in India, Bangladesh,
Bhutan, Myanmar, and Nepal [2, 4, 8–10]. Bungarus
niger is superficially similar in appearance to the lesser
black krait (Bungarus lividus) (Fig. 1) which has
caused fatalities in India and Nepal [5]. However, B.
niger is distinguishable from B. lividus based on the
size and shape of the middorsal row of scales (Fig. 1).
Although B. niger has been recognized as a distinct
species for more than a century, only a single series of
five confirmed cases of envenomation by this species
in Bangladesh has been published [4, 11]. Strikingly, B.
niger was found to cause both neurotoxic and myotoxic
envenomation in victims as well as in animal models, a
new syndrome of snakebite envenomation in South Asia
that entails additional clinical challenges [5]. Available
antivenoms in this region, produced by various Indian
manufacturers, are raised against only four species of ven-
omous snakes, namely, common krait (B. caeruleus), spec-
tacled cobra (Naja naja), Russell’s viper (Daboia russelii),
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and saw-scaled viper (Echis carinatus) [1]. Whether
or not these or other antivenoms can neutralize the
lethal effects of B. niger venom is still unknown. In
the present study, we present the first case of B. niger
envenomation in Nepal.
Case presentation
A 33-year-old male laborer found a snake on the out-
door corridor of his house at Golbasti, Ilam municipal-
ity, Ilam district, in the eastern hills of Nepal (N
26.89874°, E 87.91900°, elevation 1515 m a.s.l.) at 6:30
p.m. on 4 August 2012. Believing that it was a non-
venomous snake, he picked it up and carelessly handled
the snake. The victim, who had been under the influence
of locally produced alcoholic drink (“Jaand”), hit the
back of the snake once with a wooden plank and then
picked the snake up again and played with it joining its
head with the tail. When his wife urged him not to
handle the snake, he replied that the snakes in the hills
of Nepal were non-venomous. Unresponsive to advice,
the man touched and pressed the injured back of the
snake. In this moment, at 7:00 p.m., the snake bit the
index finger of his right hand. The man then picked
the snake up and put it in a bucket.
After the bite, the patient’s brother applied a tourni-
quet to his forearm. The patient then walked for about
10 min to his neighbor’s house. The neighbor immedi-
ately carried him on a motorcycle to the hospital in Ilam
Bazaar (Ilam district, Nepal, distance 2.2 km) where he
arrived at 7:30 p.m. On admission, there were fang
marks indicating multiple bites with slight bleeding from
the bite sites. Healthcare staff washed the finger, applied
a crepe bandage, and infused saline over 30 min. At 8:00
p.m., the patient was suffering from burning sensation at
the bite site and appeared significantly ill, he had de-
veloped bilateral ptosis, difficulty in speaking, slurred
speech, and had pain in the chest and abdomen. More-
over, he vomited for the first time. As antivenom was
not available in this hospital, arrangements were made
to transfer the patient to the snakebite treatment center
of Charali in Jhapa district. At 8:30 p.m., the ambulance
went from Ilam to Charali with the patient. At 9:00 p.m.,
difficulty in speaking increased so the patient started to
communicate by nodding his head, shaking his hands
and writing something with his index finger which his
illiterate wife could not understand. He also vomited for
a second time and, at 9:15 p.m. and 10:30 p.m., a third
and fourth time. At 10:50 p.m., when the ambulance
reached Charali, the patient was semi-conscious.
On admission to the Charali Snakebite Treatment Cen-
ter (about 4 h after the bite), the attending healthcare staff
were not able to find any fang marks, presumably as
an effect of the bite site having been washed at Ilam
Hospital. There was no detectable swelling or inflam-
mation. However, bilateral ptosis, difficulty in swallowing,
slurred speech, and difficulty in speaking were recorded at
11:00 p.m. Antivenom was administered at 11:15 p.m. in
an initial bolus dose of 100 mL of polyvalent anti-snake
venom serum (produced by VINS Bioproducts Ltd., tar-
geted against B. caeruleus, N. naja, E. carinatus, and D.
russelii snake venoms) preceded by a subcutaneous in-
jection of adrenaline (0.25 mL of 1:1000 solution) [12].
Atropine (0.6 mg) and neostigmine (0.5 mg) were given
with the same infusion as an attempt of anticholinesterase
treatment. At 11:20 p.m., the patient vomited for the fifth
time and received antiemetic treatment in the form of
an intravenous injection of metoclopramide (10 mg). At
11:35 p.m., the patient showed rashes near the infusion
cannula at the left hand and was given an intravenous
injection of pheniramine maleate (10 mg). The same dos-
age of atropine and neostigmine treatment was repeated
Fig. 1 Dorsal view of a Bungarus niger and b Bungarus lividus. The
entirely black dorsum of both species distinguishes them from other
South Asian kraits. In (a) B. niger the middorsal scales along the
vertebral column (red arrows) are greatly enlarged and hexagonal in
shape, whereas in (b) B. lividus the middorsal scales are similar in size
and shape to those of adjacent scale rows (photo by Deb
Prasad Pandey)
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at 11:45 p.m., although the first injections had not resulted
in any improvement.
At 00:05 a.m. on 5 August 2012, the following symp-
toms were noted: the patient was unable to speak, could
not protrude the tongue, swallow, or frown. A second
dose of 100 mL of antivenom was injected and his
airways cleared using a suction pump. At 00:15 a.m. he
was again given atropine and neostigmine (0.6 and 0.5
mg, respectively). At 00:25 a.m., the patient was re-
evaluated and found to show no improvement. At 00:30
a.m., he received a third dose of 100 mL of antivenom
by slow intravenous bolus injection. By this time, the
patient’s respiratory rate was altered, his blood pressure
lowered, and blood oxygen level decreased. Attempts
were made to intubate the patient but failed three times.
Then, attempts were made to manually ventilate him
with a mask and Ambu bag. When his pulse rate decreased
to 55, he was given atropine (0.6 mg, subcutaneously)
which increased the rate. At 00:45 a.m., endotracheal intub-
ation was successful, but the patient’s blood oxygen level
was down to 40 % and his blood pressure dropped, imme-
diately followed by cardiac arrest. Cardiopulmonary resusci-
tation was attempted until he was declared dead at 01:00
a.m. (8 h after the bite). Because of the absence of labora-
tory facilities in the Charali Snakebite Treatment Center, no
information on the patient’s ECG, potassium and sodium
levels, total leucocyte count, blood urea, creatine kinase,
albumin, myoglobin or blood cells in urine was available.
The snake specimen brought to the Charali Snakebite
Treatment Center by the snakebite victim was a male B.
niger measuring 1,357 mm in total length. The snake was
labelled and preserved in 70 % ethanol. After morpho-
logical examination and taxonomic identification by one
of the authors (DPP), it was permanently deposited in the
snake collection of the B. P. Koirala Institute of Health
Sciences, Dharan, Nepal (voucher number 02-023).
Discussion
This is the first report of B. niger bite envenomation in
Nepal, and only the second record of this species from
this country. This case report highlights the diversity of
snake species causing fatalities in Nepal, and emphasizes
the need of preserving snakes brought by snakebite
victims to better understand snakebite epidemiology. In
addition, it corroborates recent publications describing
previously overlooked snake species that contribute to
snakebite mortality in South Asia [1, 4, 13].
Including the present one, six proven cases of B. niger
envenomation with three fatalities have been reported
since these snakes had first been recognized as a distinct
species, in the year 1908 [11]. Five of the bites occurred
in Bangladesh [4]. The known altitudinal distribution of
this species ranges from near sea level in Bangladesh up
to at least 1,500 m in Nepal [4, 8, 14]. As there are records
of this species from India, western and eastern Nepal, and
two records in the mid-western and eastern hills of Nepal
(the present one), B. niger may be expected to occur
throughout the latter country [8, 10, 15, 16]. Moreover, it
may be potentially found at lower and higher altitudes
than those of the two presently known collecting sites
(1,450 and 1,515 m). In Bangladesh, B. niger inflicted bites
(n = 3) while being handled (like the present case), on
sleeping people (n = 2), and on a person who was cutting
wood [4]. Similar to B. caeruleus bites, B. niger bites
occurred in and around houses in the evening (present
case), at night (n = 1, 2:00 a.m.), and in the morning (4:00
to 9:00 a.m.) [4, 17–19]. Therefore, people should be
careful while performing household and field activities
especially at twilight and night during the rainy season
(July-August) [10].
Most of the community people we have talked to in
the highlands of Nepal believe that the deadly venomous
nocturnal kraits are absent in the hills. The victim, his
family members, and other locals did not know that this
snake was venomous. Tillack and Grossmann [10] re-
ported a similar ignorance of this species among inhabi-
tants of the western hills of Nepal when they first
recorded B. niger there. In the present case, the snake
apparently was quite docile initially and did not attempt
to bite until it was seriously injured. This kind of
inoffensive behavior, typical of most kraits at least during
daytime, may be misleading villagers who think that
these snakes are not dangerous.
Although the B. niger bite occurred in a place connected
by a gravel (0.5 km) and paved road (74 km) with the
nearest Snakebite Treatment Center in Charali, Jhapa
district, accessible by a four-wheel vehicle within 10 to 30
min, the patient lost precious time (about 1 h) getting to
the local health facility where no antivenom was available.
This highlights a need for informing people about the
nearest healthcare facility that delivers adequate treatment
for snakebite envenomation and has antivenom (a WHO
recognized ‘essential drug’) on stock.
In contrast to the B. niger bite cases in Bangladesh,
we could not evaluate the possibility of myotoxic en-
venomation and ensuing complications in this patient
(i.e., rhabdomyolysis, myoglobinuria, hyperkalemia, acute
renal failure, etc.) because of the absence of laboratory
facilities [4]. We noted symptoms of burning sensation at
the bite site, bilateral ptosis, abdominal pain, and fre-
quent vomiting similar to B. caeruleus and B. lividus
envenomation [5, 17, 18].
In the Bangladesh series of B. niger envenomation, three
of the five patients recovered completely after about 3 to
10 days (two of these requiring mechanical ventilation and
treatment with antivenom), and two died within 47 h after
the bite due to respiratory paralysis and acute renal failure
[4]. Collectively, these observations indicate delayed or no
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recovery after envenomation, despite the administration
of Indian polyvalent antivenoms. The efficacy of the
currently available antivenoms in the treatment of B. niger
envenomation is therefore doubtful.
Conclusions
Although only six proven cases of envenomation by B.
niger have been published from Bangladesh and Nepal,
more fatalities due to the bite of this species can be
expected to occur in a large region of South Asia.
Epidemiological studies aimed at identifying the snake
species responsible for bites should therefore be con-
ducted. Community-based health education, highlighting
simple messages on snakebite prevention and rapid
transport of victims to appropriate medical care, should
be reinforced. Health care workers in snakebite treat-
ment centers and ambulances in South Asia and beyond
should be trained to perform intubation and assisted
ventilation as a priority, as currently available antive-
noms are unlikely to be effective against envenomation
by B. niger (and probably other Bungarus species). Fur-
thermore, methods of preventing and treating acute renal
failure –as an additional possible clinical challenge after
bites by this and other snake species– should be included
in training programs [20].
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